This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Corbus Pharmaceuticals Holdings Inc. rallied 6.2% to $8.25 on what proved to be an all-around poor trading session for the stock market, with the Dow Jones Industrial Average remaining mostly unchanged at 49,499.20 and the NASDAQ Composite Index falling 1.2% to 22,878.38.

This was the stock's third consecutive day of gains.

Corbus Pharmaceuticals Holdings Inc. closed 59.9% below its 52-week high of $20.56, which the company achieved on October 20th.

The stock outperformed some of its peers, as Vanda Pharmaceuticals Inc. rose 3.9% to $8.60, Fortress Biotech Inc. fell 0.8% to $3.52, and Viking Therapeutics Inc. fell 0.45% to $32.97.

Trading volume totaled 443,812, compared to the 50-day average of 182,759.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

February 26, 2026 16:34 ET (21:34 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.